Dynavax Technologies Corp. (DVAX)

$ 15.38
   
  • Change Today:
    $4.25
  • 52 Week High: $15.49
  • 52 Week Low: $9.36
  • Currency: US Dollars
  • Shares Issued: 65.06m
  • Volume: 30,747,058
  • Market Cap: $1,000.68m
  • RiskGrade: 699

DVAX Overview

1 Day Chart (24-12-2025)

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

DVAX Fundamentals

Fundamentals data is not available for this company.

DVAX Forecasts

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-25 338.75 9.54 (32.88)¢ n/a n/a n/a n/a 0.0%
31-Dec-26 392.42 49.22 45.00¢ 34.2 n/a n/a n/a 0.0%
31-Dec-27 451.35 82.66 65.41¢ 23.5 0.5 +45% n/a 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

DVAX ShareCast News

No recent information was found.

DVAX Top Newspaper Links

Dynavax, Merck team up on hepatitis B vaccine 02-Nov-2007 BayArea.com
Merck Buys License to Sell New Vaccine for Hepat... 01-Nov-2007 New York Times
Business Digest 20-Jan-2006 BayArea.com

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

DVAX Market Data

Currency US Dollars
Share Price $ 15.38
Change Today $ 4.25
% Change 38.19 %
52 Week High $15.49
52 Week Low $9.36
Volume 30,747,058
Shares Issued 65.06m
Market Cap $1,000.68m
RiskGrade 699

What The Brokers Say

Strong Buy 1
Buy 2
Neutral 0
Sell 1
Strong Sell 0
Total 4
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for --2025

Time Volume / Share Price
0 @ $0.00

Top of Page